至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Novel silica forming peptide, RSGH, from Equus caballus: Its unique biosilica formation under acidic conditions

Biochemical Engineering Journal. 2020; 
Ki HaMinaKi BaekYeoaMi-RanKiaSang HoJunbSeung PilPacka
Products/Services Used Details Operation
Peptide Synthesis The R5, Equus and RSGH peptides (10 mg) were synthesized by Genscript (Piscataway, NJ). Tetramethylorthosilicate (TMOS) was employed as a silica precursor and purchased from Sigma Aldrich (St. Louis, MO); The yeast cells used were Saccharomyces cerevisiae EBY 100, provided from the Ajou University (Suwon, Korea). Get A Quote

摘要

A novel silica forming peptide (SFP), RSGH was designated on the basis of the peptide found from Equus caballus and investigated for its ability to precipitate biosilica under acidic conditions, where biosilica is not easily formed. At pH values of 4, 5 and 6, RSGH showed better performance in the generation of silica particles than the most well-known SFP, silaffin R5, and the amount of the produced biosilica particles increased with the concentration of the peptide. We also demonstrated that RSGH could induce biosilica formation for the processes requiring a low pH, such as silica shell-coating of yeast cells. The RSGH peptide could adsorb to the yeast wall and generate a biosilica shell on the cell surface... More

关键词